|
Cory, J G; Cory, A H; Raber, N K et al. (1993) Structural aspects of N-hydroxy-N'-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity. Adv Enzyme Regul 33:129-40
|
|
Cory, J G; Downes, D L; Ng, C Y et al. (1992) 5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells. Oncol Res 4:175-9
|
|
Carter, G L; Cory, J G (1992) Factors affecting the mRNA levels for the non-heme iron and effector-binding subunits of ribonucleotide reductase. Adv Enzyme Regul 32:227-40
|
|
Cory, A H; Owen, T C; Barltrop, J A et al. (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3:207-12
|
|
Tihan, T; Elford, H L; Cory, J G (1991) Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime. Adv Enzyme Regul 31:71-83
|
|
Matsumoto, M; Tihan, T; Cory, J G (1990) Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture. Cancer Chemother Pharmacol 26:323-9
|
|
Matsumoto, M; Weckbecker, G; Cory, J G (1990) Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells. Cancer Commun 2:1-6
|
|
Cory, J G; Halley, M C; Jeney, A et al. (1990) 5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in culture. Cancer Res 50:4552-6
|
|
Weckbecker, G; Cory, J G (1989) Metabolic activation of 2,6-diaminopurine and 2,6-diaminopurine-2'-deoxyriboside to antitumor agents. Adv Enzyme Regul 28:125-44
|
|
Carter, G L; Cory, J G (1989) Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase. Adv Enzyme Regul 29:123-39
|
Showing the most recent 10 out of 26 publications
